0001964306-23-000083.txt : 20230612 0001964306-23-000083.hdr.sgml : 20230612 20230612190844 ACCESSION NUMBER: 0001964306-23-000083 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230612 DATE AS OF CHANGE: 20230612 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823562771 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 231009800 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: MOORE ALISON CENTRAL INDEX KEY: 0001754937 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ALLOGENE THERAPEUTICS, INC. STREET 2: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 144 1 primary_doc.xml 144 0001754937 XXXXXXXX LIVE 0001737287 Allogene Therapeutics, Inc. 001-38693 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700 MOORE ALISON Officer Common Stock Merrill Lynch

225 Liberty St Floor 37 New York NY 10281

531854 3052841.96 145841620 06/12/2023 NASDAQ Common Stock 06/12/2023 Exercise of employee stock options Allogene Therapeutics, Inc. N 437080 06/12/2023 Broker assisted cashless exercise Common Stock 06/28/2019 Exercise of employee stock options Allogene Therapeutics, Inc. N 498 06/28/2019 Cash Common Stock 03/13/2020 Vesting of restricted stock unit award Allogene Therapeutics, Inc. N 5512 03/13/2020 Granted as part of issuer equity compensation plan Common Stock 08/13/2020 Exercise of employee stock options Allogene Therapeutics, Inc N 32451 08/13/2020 Cash Common Stock 03/13/2021 Vesting of restricted stock unit award Allogene Therapeutics, Inc. N 10799 03/13/2021 Granted as part of issuer equity compensation plan Common Stock 03/13/2022 Vesting of restricted stock unit award Allogene Therapeutics, Inc. N 23178 03/13/2022 Granted as part of issuer equity compensation plan Common Stock 03/13/2023 Vesting of restricted stock unit award Allogene Therapeutics, Inc. N 14829 03/13/2023 Granted as part of issuer equity compensation plan Common Stock 03/15/2023 Employee stock purchase plan Allogene Therapeutics, Inc. N 2000 03/15/2023 Cash Common Stock 03/15/2022 Employee stock purchase plan Allogene Therapeutics, Inc. N 1688 03/15/2022 Cash Common Stock 09/15/2021 Employee stock purchase plan Allogene Therapeutics, Inc. N 558 09/15/2021 Cash Common Stock 03/15/2021 Employee stock purchase plan Allogene Therapeutics, Inc. N 368 03/15/2021 Cash Common Stock 09/15/2020 Employee stock purchase plan Allogene Therapeutics, Inc. N 718 09/15/2020 Cash Common Stock 03/13/2020 Employee stock purchase plan Allogene Therapeutics, Inc. N 704 03/13/2020 Cash Common Stock 09/13/2019 Employee stock purchase plan Allogene Therapeutics, Inc. N 694 09/13/2019 Cash Common Stock 03/15/2019 Employee stock purchase plan Allogene Therapeutics, Inc. N 507 03/15/2019 Cash N Alison Moore

210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080

Common Stock 03/14/2023 8351 45989.75 06/12/2023 Alison Moore